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Abstract
The rate-limiting step in the biosynthesis of steroid hormones, known as the transfer of cholesterol from the outer to the
inner mitochondrial membrane, is facilitated by StAR, the Steroidogenic Acute Regulatory protein. We have described that
mitochondrial ERK1/2 phosphorylates StAR and that mitochondrial fusion, through the up-regulation of a fusion protein
Mitofusin 2, is essential during steroidogenesis. Here, we demonstrate that mitochondrial StAR together with mitochondrial
active ERK and PKA are necessary for maximal steroid production. Phosphorylation of StAR by ERK is required for the
maintenance of this protein in mitochondria, observed by means of over-expression of a StAR variant lacking the ERK
phosphorylation residue. Mitochondrial fusion regulates StAR levels in mitochondria after hormone stimulation. In this
study, Mitofusin 2 knockdown and mitochondrial fusion inhibition in MA-10 Leydig cells diminished StAR mRNA levels and
concomitantly mitochondrial StAR protein. Together our results unveil the requirement of mitochondrial fusion in the
regulation of the localization and mRNA abundance of StAR. We here establish the relevance of mitochondrial
phosphorylation events in the correct localization of this key protein to exert its action in specialized cells. These discoveries
highlight the importance of mitochondrial fusion and ERK phosphorylation in cholesterol transport by means of directing
StAR to the outer mitochondrial membrane to achieve a large number of steroid molecules per unit of StAR.
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Introduction
Mitochondria are a key control point for the regulation of
steroid hormone biosynthesis. The transport of cholesterol across
the intermembrane space from the outer (OMM) to the inner
mitochondrial membrane [1] provides the substrate for all steroid
hormones. This point is the first and rate-limiting step in
steroidogenesis [2,3,4] which is facilitated, among other proteins,
by the Steroidogenic Acute Regulatory (StAR) protein [5,6]. StAR
protein is synthesized as a 37 kDa preprotein with a typical
mitochondrial leader sequence; upon hormonal stimulation it is
translocated to yield a mature 30 kDa mitochondrial protein [7,8].
StAR mediates the rapid flow of cholesterol from the OMM to the
IMM, enabling steroidogenic cells to make a large amount of
steroids in a short period of time. A small amount of StAR has
been reported to elicit cholesterol transport to achieve the
maximal rate of steroid synthesis [9]. Compelling previous studies
indicate that StAR functionally promotes steroidogenesis exclu-
sively at the OMM, even in the absence of the mitochondrial
import sequence and loses activity when it reaches the mitochon-
drial matrix [10,11,12,13]. Furthermore, it has been reported that
StAR’s activity is proportional to how long it remains on the
OMM [14]. There is also evidence that inner mitochondrial
proteolysis in adrenal cells is essential in cholesterol fluxes, with a
role of StAR in the IMM [9,15]. Thus, the mechanisms of StAR
import and processing remain unclear. Once synthesized, StAR
preprotein must quickly associate with the mitochondria or
otherwise it could be rapidly degraded in the cytosol. The
protophonore carbonyl cyanide m-chlorophenyl hydrazone
(CCCP), which disrupts the mitochondrial membrane potential
(DYm), prevents the appearence of 30 kDa StAR in the
mitochondria, which suggests that StAR import into the
mitochondrial matrix and its subsequent processing are dependent
on an intact DYm [9,16,17]. After hormone stimulation, StAR is
associated with a mitochondrial multiprotein complex [18]. In this
regard, Rone and co-workers have recently described a 800-kDa
mitochondrial bioactive complex named ‘‘transduceome’’, con-
taining the OMM translocator protein (18 kDa, TSPO) and the
voltage-dependent anion channel (VDAC) along with other
proteins, essential for cholesterol metabolism [19]. Particularly,
VDAC1 interacts with bioactive phosphorylated StAR at the
OMM, facilitating its activity [20].
It is well known that cAMP-dependent protein kinase (PKA)
activation increases StAR gene transcription [21,22,23] and other
kinases, such as ERK1/2, regulating steroidogenesis by genomic
and non-genomic effects [24,25,26,27,28,29]. Several groups,
including ours, have shown that ERK1/2 and MEK1/2 are
targeted to the mitochondria in different tissues, particularly at the
OMM [30,31] and that mitochondrial ERK1/2 is a cholesterol
transport regulator modulating StAR phosphorylation [28].
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Mitochondrial fusion/fission events are critically important for
maintaining the integrity of these organelles [32]. Two dynamin-
like GTPases, Mitofusin (Mfn) 1 and 2, are involved in
mitochondrial fusion. They are implicated in the modulation of
mitochondria-mitochondria and endoplasmic reticulum (ER)-
mitochondria interactions. We have previously shown that steroid
synthesis involves both types of fusion, the association between
mitochondria and between mitochondria and ER membranes,
known as MAM (mitochondria-associated membranes) [33].
Regulation of cholesterol transport implicates fusion of mitochon-
dria through the increase of mitochondrial Mfn2, along with StAR
phosphorylation by PKA and ERK [28,33,34,35].
In this study, we evaluated the contribution of mitochondrial
fusion and ERK phosphorylation in StAR synthesis and
mitochondrial localization. We observed that StAR activity
depends on the correct activation and localization of mitochon-
drial ERK in the temporal frame of kinase activity. We showed for
the first time that StAR depends on mitochondrial fusion to reach
the mitochondria where it is retained through a mechanism
involving ERK phosphorylation in the presence of cholesterol.
Here, we highlight the fact that StAR site of action is effectively
the OMM, which establishes a StAR activity cycle that could in
turn enable the metabolism of many molecules of cholesterol per
unit of StAR protein.
Materials and Methods
Materials
Purified hCG was provided by Dr. Parlow (National Hormone
and Pituitary Program, National Institute of Diabetes & Digestive
& Kidney Diseases; NIDDK, NIH, Bethesda, MD, USA).
Waymouth MB752/1 cell culture media, acrylamide, bis.acryla-
mide, agarose, BSA, 8-bromoadenosine 39:59-cyclic monophos-
phate (8Br-cAMP), H89, 22(R)-OH-cholesterol and carbonyl
cyanide m-chlorophenyl hydrazone (CCCP) were purchased from
Sigma Chemical Co. (St. Louis, MO, USA). Serum, antibiotics,
trypsin-EDTA and Lipofectamine 2000 were from Life Technol-
ogies, Inc. (Gaithersburg, MD, USA). Tri-Reagent was from
Molecular Research Center Inc. (Cincinnati, USA). Electropho-
resis supplies, polyvinylidendifluoride membrane (PVDF) and
secondary antibody (horseradish peroxidase conjugated goat
antibody) were from Bio-Rad Laboratories Inc. (Hercules, CA,
USA). Antibodies against Mfn2 and StAR FL (full length) were
obtained from Santa Cruz Biotechnology Inc. (Dallas, Texas,
USA). Anti-OxPhos complex III core 2 subunit (III Complex) was
purchased from Invitrogen (Carlsbad, CA, USA). M-MLV reverse
transcriptase (RT), GoTaq DNA polymerase and other molecular
biology reagents were purchased from Promega (Madison, WI,
USA). PD98509 was obtained from Calbiochem (San Diego, CA,
USA). SYBR Select Master Mix was obtained from Applied
Biosystems (Carlsbad, CA, USA). Sterile and plastic material for
tissue culture was from Orange Scientific (Braine-l’Alleud,
Belgium). All other reagents were of the highest grade available.
Cell Culture
The MA-10 cell line is a clonal strain of mouse Leydig tumor
cells that produces progesterone (P4) rather that testosterone as the
main steroid [36]. MA-10 cells were generously provided by Mario
Ascoli from the University of Iowa, College of Medicine (Iowa
City, IA) [36] and were handled as described previously [28]. Cells
were maintained in Waymouth MB752/1 growth medium,
containing 1.1 g/l NaHCO3, 20 mM HEPES, 50 mg/ml genta-
micin and 15% heat-inactivated horse serum. Cells were
maintained at 36uC in a humidified atmosphere containing 5%
CO2. Purified hCG with a biological potency of 11900 IU/mg or
8Br-cAMP, a permeable analog of cyclic-AMP, were used to treat
the cells for the indicated times.
Cell Transfection and Plasmid Constructions
Cells were transiently transfected using Lipofectamine 2000
reagent and transfection was performed with pRc/CMVi plasmid
either containing StAR wild-type cDNA (StAR wt) or StAR
mutated cDNA (StAR S232A), as we used previously [28]. In
another set of experiments, cells were transfected with pSUPER.-
retro plasmid containing the Mfn2-shRNA as described previously
[33]. In all cases, empty vectors were used as control (mock
transfection).
Phosphorylation and Import/translocation Assay
1.5 mg of the pRc/CMVi plasmid containing cDNA sequence
from StAR wt and StAR S232A were transcribed/translated
in vitro using the Rabbit Reticulocyte Lysate System (Promega
Corp. Madison, WI, USA). Plasmids were incubated separately in
70 ml of the master mix, supplemented with L-Methionine as
indicated by the manufacturer, plus 300 mg of mitochondrial
fraction obtained from control MA-10 cells in import buffer, as
previously described [37]. After 30 min incubation at 30uC, 1 mg
of constitutively active His-tagged ERK1 (Calbiochem-Millipore,
MA, USA) in the phosphorylation mixture (20 mM MOPS pH
7.5, 10 mM MgCl2, 5 mM EGTA, 2610
24% Tween-20, 100 mM
ATP, 1 mM sodium orthovanadate, 1 mM DTT) was added plus
10 mCi of [c-32P]ATP and 50 mM of cholesterol. The reaction
continued for other 30 min at 30uC and was finished after 1 h by
the addition of 25 mM FCCP for 10 min. at 4uC. The samples
were centrifuged at 200006g for 20 min and the mitochondrial
pellet was resuspended in MSHE buffer, as previously described
[28]. Then, mitochondrial fraction was separated by SDS-PAGE
electrophoresis. The PVDF membranes were subjected to
autoradiography and immunoblots were performed using anti-
bodies anti-pERK and anti-StAR.
Cell-free Assay for Mitochondrial Steroidogenesis
Cells were treated as indicated in the corresponding figure.
Then, subcellular fractionation and measurement of mitochondri-
al steroidogenesis was performed according to our published
procedures [28]. Mitochondria were incubated in the presence of
cholesterol (50 mM) as substrate for 30 min at 30uC. Incubations
were performed in the absence or presence of 1 mg of constitu-
tively active His-tagged ERK1 together with 1 IU of PKA catalytic
subunit (Sigma Chemical Co., St. Louis, MO, USA). Then, P4
production in the incubation media was determined by radioim-
munoassay [33].
Protein Quantification and Western Blot
Mitochondria were isolated as described previously [38].
Mitochondrial proteins were determined by Bradfords method
[39] and were subjected to SDS-PAGE as described previously
[40]. Membranes were then incubated with the primary antibodies
anti-Mfn2 (1:1000) [33], anti-phospho ERK (1:1000) or anti-StAR
(1:1000) [28]. Then, anti-III Complex (1:10000) and anti-total
ERK antibodies (1:1000) were used to normalize the results [33].
RNA Extraction, Semi-quantitative RT-PCR and Real-time
PCR
MA-10 Leydig cells total RNA was extracted using Tri-Reagent
following the manufacturer’s instructions. Two mg of total RNA
Mitochondrial Fusion and ERK in StAR Action
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Figure 1. Mitochondrial StAR protein per se is not enough to sustain steroidogenesis stimulated by cAMP. Design of two-phase
experiments. A. Cells were incubated in the absence or presence of 8Br-cAMP (cAMP) (1 mM) and CCCP (5 mM) for 1 h or 2 h (Phase I; Treatment).
Here, the proteasome inhibitor MG132 (MG; 5 mM) was used to avoid cytoplasmatic StAR degradation. Then, these additives were removed (wash-
out) with fresh media (Phase II; Recovery). Among cells incubated with cAMP plus CCCP, those treated for 2 h in Phase I recovered after 2 h in Phase
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were reverse transcribed using random hexamers and M-MLV
Reverse Transcriptase according to the manufacturer’s protocol.
For semi-quantitative RT-PCR, the following specific primers
were used: mouse StAR cDNA forward, 59-GGGACGAAGTGC-
TAAGTAAGATGG-39 and reverse, 59-GGTCAATGTGGA-
CAGTCC-39 (amplicon size 566-bp); and mouse ribosomal
protein L19 cDNA forward, 59-GAAATCGCCAATGC-
CAACTC-39 and reverse, 59-TCTTAGACCTGC-
GAGCCTCA-39 (amplicon size 405-bp) [41]. Primers were
obtained from Invitrogen (Carlsbad, CA, USA). Reaction condi-
tions were one cycle at 94uC for 5 min, followed by 22 cycles (for
StAR) or 23 cycles (for L19) at 94uC for 30 sec, 55uC for 30 sec,
and 72uC for 30 sec, and one final cycle at 72uC for 10 min. The
number of cycles used was optimized for each gene to fall within
the linear range of PCR amplification. PCR products were
resolved on a 1.5% (wt/vol) agarose gel containing 0.5 mg/ml of
ethidium bromide to determine the molecular sizes of the StAR
and L19 amplicons. Gel images were acquired with a GelPro
analyzer (IPS, North Reading, MA). Levels of StAR and L19
mRNA were quantified with a computer-assisted image analyzer
(ImageQuant 5.2) and PCR results for each sample were
normalized by L19 mRNA as an internal control.
For Real-Time PCR, the following specific primers were used:
mouse StAR cDNA forward, 59-TTGGGCATACTCAA-
CAACCA-39 and reverse, 59-CTTGACATTTGGGTTCCAC-
39 [42]; and mouse 18S RNA forward, 59-ATTCCGATAAC-
GAACGAGACT-39 and reverse, 59-AGCTTATGACCCG-
CACTTACT-39 (obtained from RealTimePrimers.com, Elkins
Park, PA, USA). Real-time PCR was performed using Applied
Biosystems 7300 Real-Time PCR System. For each reaction, 20 ml
of solution containing 5 ml of cDNA, 10 mM forward and reverse
primers, and 10 ml of SYBR Select Master Mix was used. All
reactions were performed in triplicate. Amplification was initiated
by a 2-min preincubation at 50uC, 2-min incubation at 95uC,
followed by 40 cycles at 95uC for 15 sec, 55uC for 15 sec and 72uC
for 1 min, terminating at 95uC for the last 15 sec. StAR mRNA
expression levels were normalized to mouse 18S RNA expression,
performed in parallel as endogenous control. Real-time PCR data
were analyzed by calculating the 22DDCt value (comparative Ct
method) for each experimental sample.
Radioimmunoanalysis [33] and Statistics
P4 production in cell culture media was measured by RIA as
described previously [40]. Statistical significance was determined
by Student’s t test or analysis of variance (ANOVA) followed by
Student-Newman-Kuels test.
Results
Maximal Steroid Synthesis Depends on Mitochondrial
Mediators Supporting StAR Function
CCCP mediated-DYm disruption effects on StAR metabolism,
mitochondrial import and steroidogenesis after hormone stimula-
tion have been previously shown in MA-10 Leydig cells [9,16,43].
The well-known effects of this protonophore on membrane
potential, mitochondrial import qualities and normal mitochon-
drial dynamics are entirely reversible [33,44,45]. Even though the
effect of CCCP removal on StAR processing and localization has
already been described [16,17], there is no evidence of the
recovery of steroid synthesis after the re-establishment of the
DYm. Therefore, we evaluated mitochondrial StAR and steroido-
genesis after inhibition and subsequent restoration of the DYm.
To address this issue, we performed a two-phase experiment, as
shown in Figure 1A. In Phase I (Treatment), MA-10 cells were
stimulated with 8Br-cAMP (cAMP) in the presence or absence of
CCCP. In Phase II (Recovery), after CCCP wash-out, fresh
medium was added to remove both the stimulant and the
uncoupling agent. Phase II measures the capacity of newly
synthesized StAR (generated in Phase I) to localize efficiently in
mitochondria after DYm is restored. Among cells incubated with
cAMP plus CCCP, those treated for 2 h in Phase I recovered after
2 h in Phase II, while those treated for 1 h in Phase I recovered
after 3 h in Phase II, reaching in both cases a 4 h final
experimental time (Figure 1A). As seen in Figure 1B, the levels
of mitochondrial StAR are clearly detected by immunoblot after 1
and 2 h stimulation with cAMP (see second and forth lanes), but
very low StAR levels are observed after 1 and 2 h stimulation with
cAMP in the presence of CCCP (see third and fifth lanes).
Figure 1C shows mitochondrial StAR recovery after CCCP
removal in Phase II, with a clear presence after 2 h and robust
increase after 3 h (Fig. 1C, Recovery Time 2 and 3 h). The
inhibitory effect of CCCP and its recovery in Phase II are also
observed in StAR mRNA levels (Figure S1).
Next, we analyzed the impact of the two-phase assay on
cholesterol metabolism, measured as P4 production. Figure 1D
shows that, as expected, P4 production in the presence of cAMP is
abrogated by CCCP at every time analyzed in Phase I (left half
panel) and not reactivated after CCCP elimination (right half
panel) in Phase II, even when immunoblot revealed StAR
presence in the mitochondria. In turn, the stimulation of steroid
synthesis sustained by 22(R)-OH-cholesterol (a permeable analog
of cholesterol) was not statistically different in the presence or
absence of CCCP. These findings, shown in Table S1, indicate
that P4 synthesis inhibition in the presence of CCCP is not due to
mitochondrial enzyme damage.
Given that mitochondrial StAR is not enough to reactivate
complete steroidogenesis, these results suggest that steroid
II, while those treated for 1 h in Phase I recovered after 3 h in Phase II, reaching in both cases a 4 h final experimental time. B. Mitochondrial proteins
from cells in Phase I were obtained and western blotting was performed. Membranes were sequentially blotted for StAR and III Complex. A
representative western blot is shown. For each band, the OD of expression levels of StAR protein were quantified (arbitrary units) and normalized to
the corresponding III Complex protein. The relative levels of StAR protein are shown: ¥¥¥ p,0.001 vs. control; ***p,0.001 vs. cAMP alone. C. In
another set of experiments, cells were sequentially subjected to Phase I and II, thereafter mitochondrial proteins were isolated and western blotting
was performed as indicated in panel B. The relative levels of StAR protein are shown: ### p,0.001 vs. 1 h cAMP +CCCP in Phase I; ## p,0.01 vs.
2 h cAMP +CCCP in Phase I. D. P4 production in the culture media from Phase I and II was measured by RIA and data are shown as P4 concentration
(ng/ml): ¥¥¥ p,0.001 vs. control; ***p,0.001 vs. cAMP alone in Phase I, **p,0.01 vs. cAMP alone in Phase I, ### p,0.001 vs. recovery from cAMP
alone. E. Mitochondrial proteins from cells in Phase I were obtained and western blotting was performed. Membranes were sequentially blotted for
phospho-ERK1/2 (pERK) and total ERK1/2 (tERK). A representative western blot is shown. For each band, the OD of expression levels of pERK were
quantified (arbitrary units) and normalized to the corresponding tERK protein. The relative levels of pERK are shown: ***p,0.001 vs. control, **p,0.01
vs. control, ### p,0.001 vs. 1 h cAMP alone, ## p,0.01 vs. 2 h cAMP alone. F. In another set of experiments, cells were sequentially subjected to
Phase I and II, thereafter mitochondrial proteins were isolated and western blotting was performed as indicated in panel E. The relative levels of pERK
are shown: ns p.0.05 vs. cAMP +CCCP in Phase I. Results are expressed as mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0100387.g001
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Figure 2. StAR mitochondrial levels depend on post-transcriptional events. Cells were transfected with a pRc/CMVi vector containing the
cDNA of wild type StAR full length (StAR wt). A. Cells were incubated in the absence or presence of 8Br-cAMP (cAMP) (1 mM) and CCCP (5 mM) for 1 h
or 2 h (Phase I; Treatment). Here, the proteasome inhibitor MG132 (MG; 5 mM) was used to avoid cytoplasmatic StAR degradation. Then, these
additives were removed (wash-out) with fresh media (Phase II; Recovery). Among cells incubated with cAMP plus CCCP, those treated for 2 h in Phase
I recovered after 2 h in Phase II, while those treated for 1 h in Phase I recovered after 3 h in Phase II, reaching in both cases a 4 h final experimental
time. B. Mitochondrial proteins from cells in Phase I were obtained and western blotting was performed. Membranes were sequentially blotted for
StAR and III Complex. A representative western blot is shown. For each band, the OD of expression levels of StAR protein were quantified (arbitrary
units) and normalized to the corresponding III Complex protein. The relative levels of StAR protein are shown: ¥¥¥ p,0.001 and ¥¥ p,0.01 vs. control;
### p,0.001 vs. cAMP alone. C. In another set of experiments, cells were sequentially subjected to Phase I and II, thereafter mitochondrial proteins
Mitochondrial Fusion and ERK in StAR Action
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production mediated by StAR involves the cooperation with
(an)other factor(s) in the mitochondria of steroidogenic cells,
particularly in Phase I. To adress this particular issue, we analyzed
phospho-ERK1/2 (pERK) levels in mitochondria after the two-
phase experiment. Figure 1E shows that, in agreement with
previous work (Duarte et al., 2012), mitochondrial cAMP-
stimulated pERK diminished in the presence of CCCP (see forth
and fifth lanes). Interestingly, Figure 1F shows that mitochondrial
pERK levels were not restored either after 2 or 3 h of Phase II
(Recovery Time 2 and 3 h). These results are completely in line
with the lack of steroid synthesis in Phase II, given that
were isolated and western blotting was performed as indicated in panel B. The relative levels of StAR protein are shown. D. cAMP stimulated- and
CCCP treated-cells were incubated with or without MG132 (5 mM) during Phase II. Mitochondrial proteins were obtained and western blotting was
performed as indicated in panel B: ### p,0.001 vs. 3 h Recovery Time (Phase II) without MG. Results are expressed as mean 6 SEM of three
independent experiments.
doi:10.1371/journal.pone.0100387.g002
Figure 3. ERK phosphorylation of StAR is required for the
correct association of StAR with the mitochondria. Cells were
transfected with an empty pRc/CMVi vector (mock) or containing the
StAR wt cDNA (StAR wt) or StAR mutant form (StAR S232A). After 48 h,
cells were stimulated for 1 h with A. hCG (20 ng/ml) or B. 8Br-cAMP
(cAMP) (0.5 mM). Membranes were sequentially blotted for StAR and III
Complex. Representative western blots are shown. For each band, the
OD of the expression levels of StAR protein were quantified (arbitrary
units) and normalized to the corresponding III Complex protein. The
relative levels of StAR protein are shown: A. ***p,0.001 vs. control
mock; **p,0.01 vs. control StAR wt; ### p,0.001 vs. hCG StAR wt. B.
***p,0.001 vs. control mock; **p,0.01 vs. control StAR wt; ## p,0.01
vs. cAMP StAR wt. Results are expressed as mean 6 SEM of three
independent experiments. Progesterone production was determined by
RIA in the incubation media. Results are indicated in a Table at the
bottom of each panel. Data are expressed as ng/ml of P4.
doi:10.1371/journal.pone.0100387.g003
Figure 4. ERK phosphorylation of StAR in Ser232 drives StAR
retention on the OMM. pRc/CMVi vector containing the StAR wt
cDNA (StAR wt) or StAR mutant form (StAR S232A) were subjected to a
transcription/translation import assay and in vitro phosphorylation (see
Materials and Methods). Mitochondrial proteins were separated by SDS-
PAGE, transfered to a PVDF membrane and then autoradiography and
immunoblot were performed. A. Levels of phosphorylated StAR (pStAR)
are shown in the presence or absence of active ERK1 (upper panel). The
autoradiography displays a representative result of three independent
experiments. The immunoblots (lower panels) show total mitochondrial
StAR and phospho-ERK (pERK) levels. Representative western blots are
shown. B. For each band, the OD of pStAR levels were quantified
(arbitrary units) and normalized to the corresponding total StAR protein
levels. The relative levels of pStAR are shown: ***p,0.001 vs. StAR wt
without ERK1; ### p,0.001 vs. StAR wt with ERK1. Results are
expressed as mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0100387.g004
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Figure 5. ERK and PKA are strictly required as mediators to achieve maximal steroidogenesis in the presence of mitochondrial
StAR. A. Design of two-phase experiments. Cells were incubated in the absence or presence of 8Br-cAMP (cAMP) (1 mM) and CCCP (5 mM) for 2 h
(Phase I; Treatment). Here, the proteasome inhibitor MG132 (MG; 5 mM) was used to avoid cytoplasmatic StAR degradation. Then, these additives
were removed (wash-out) with fresh media (Phase II; Recovery) for 3 h. For panels B and C, mitochondria from cells subjected to the two-phase assay
were isolated and incubated, with cholesterol (50 mM) as substrate, in the presence (grey bars) or absence (black bars) of constitutively active His-
tagged ERK1 together with PKA catalytic subunit. After the above incubations, mitochondria were pelleted, media was collected and mitochondrial
P4 production was measured by RIA. Data are shown as P4 concentration (ng/ml): B. Phase I: ns p.0.05 b vs. a; ***p,0.001 c vs. a; ## p,0.01 d vs.
c; J p,0.05 e vs. c; ns p.0.05 f vs. e. C. Phase II: ns p.0.05 h vs. g; 111 p,0.001 i vs. g; ¥¥ p,0.01 j vs. i. Results are expressed as mean 6 SEM of
three independent experiments. D. In another set of experiments, cells were sequentially subjected to Phase I and II. During Phase II, incubation was
conducted in the presence or absence of H89 (20 mM) or PD98059 (PD; 50 mM). Then, media was collected and P4 production was measured by RIA.
Data are shown as P4 concentration (ng/ml): ns p.0.05 with inhibitors alone or both vs. without inhibitors.
doi:10.1371/journal.pone.0100387.g005
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mitochondrial ERK activity is required for steroidogenesis [26,28].
In order to analyze the consequence of DYm disruption in
mitochondrial StAR protein levels, we performed a transient
transfection over-expressing StAR (Figure 2), so that the observed
effect of CCCP on endogenous StAR mRNA levels can be
excluded (Figure S1) and post-transcriptional effects can be
evaluated. The experimental protocol (Fig. 2A) was the same as
for Figure 1A. Figure 2B shows that the exogenous StAR is
localized in the mitochondria, even in absence of stimulation (see
first lane). The addition of CCCP abrogates the association of
StAR to mitochondria both in absence (see second lane) and
presence of cAMP stimulation (see fith and sixth lanes). Figure 2C
shows that mitochondrial StAR is recovered after CCCP wash-out
in Phase II in a time-dependent manner (Fig. 2C, Recovery Time
2 and 3 h). Taken together, the results presented so far reinforce
the fact that StAR is not completely effective by itself for
reactivating P4 synthesis and that mediators, probably active
ERK, are needed in Phase I to elicit maximal steroid synthesis
after mitochondrial StAR levels are restored.
Interestingly, the presence of MG132 (a proteasome inhibitor)
in Phase II increases StAR mitochondrial levels two-fold (Fig. 2D,
Recovery Time 2 and 3 h, right panel with MG), as compared to
levels observed in absence of MG132 (left panel, without MG).
Results were compared within Figure 2D, with the same gel and
autoradiography exposure time. This result suggests that the
absence of mitochondrial mediator/s due to the presence of
CCCP in Phase I makes StAR more susceptible to mitochondrial
proteases, as one of the mechanisms involved in the regulation of
mitochondrial StAR levels.
ERK-mediated Phosphorylation of StAR is Required to
Retain the Protein in Mitochondria
StAR is phosphorylated by ERK in vitro in serine 232 (Ser232), a
crucial event in StAR activity and cholesterol transport.
Mitochondrial ERK phosphorylation was followed by progressive
decrease of its activity during the first hour of hormonal action
[28]. As seen in this work, DYm is required for mitochondrial
StAR localization; nevertheless, P4 production achieved after the
Figure 6. Mfn2 protein is necessary for StAR and pERK
mitochondrial localization. Cells were transfected with an empty
pSUPER.Retro vector (mock) or containing a Mfn2-shRNA. After 48 h,
cells were stimulated with hCG (20 ng/ml) or 8Br-cAMP (cAMP)
(0.5 mM) for 1 h. Mitochondrial proteins were obtained and western
blotting was performed. Membranes were sequentially blotted with
anti-StAR, phospho-ERK (pERK) or anti-Mfn2 antibodies, and III Complex
antibody as loading control. An image of a representative western blot
is shown. For each band, the OD of expression levels of StAR and pERK
proteins were quantified (arbitrary units) and normalized to the
corresponding III Complex protein. A. The relative levels of StAR
protein are shown: ¥¥¥ p,0.001 and ¥¥ p,0.01 vs. control mock; **p,
0.01 vs. cAMP mock; # p,0.05 vs. hCG mock. B. The relative levels of
pERK protein are shown: ¥¥¥ p,0.001 vs. control mock; **p,0.01 vs.
cAMP mock; ### p,0.001 vs. hCG mock. Results are expressed as
mean 6 SEM of three independent experiments.C. An image of a
representative western blot is shown to assess shRNA knockdown
efficiency. D. Progesterone production was determined by RIA in the
incubation media. Data are expressed as ng/ml of P4.
doi:10.1371/journal.pone.0100387.g006
Figure 7. Mitochondrial fusion modulates StAR mRNA levels.
Cells were transfected with an empty pSUPER.Retro vector (mock) or
containing a Mfn2-shRNA. After 48 h, cells were incubated with or
without 8Br-cAMP (cAMP) (0.5 mM) for 1 h. Total RNA was isolated;
reverse transcribed and subjected to Real-Time PCR.using specific
primers. StAR mRNA expression levels were normalized to mouse 18S
RNA expression, performed in parallel as endogenous control. Real-time
PCR data were analyzed by calculating the 22DDCt value (comparative Ct
method) for each experimental sample. The relative expression levels of
StAR are shown: ### p,0.001 vs. control mock; ***p,0.001 vs. cAMP
mock. Results are expressed as mean 6 SEM of three independent
experiments.
doi:10.1371/journal.pone.0100387.g007
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recovery of DYm and StAR translocation is not consistent with a
fully activated protein. The inhibition of DYm with CCCP
partially blocks the association of ERK with the mitochondria
after hormone stimulation [33] and also inhibits cAMP-provoked
phosphorylation of total ERK [46] in MA-10 Leydig cells. As
ERK phosphorylation is not recovered after CCCP wash-out, we
examined the role of ERK phosphorylation in StAR localization/
retention in mitochondria and steroid synthesis. For this purpose,
we transiently transfected cells with StAR wt and StAR S232A, a
mutant form of StAR in which the Ser232 was converted to
Alanine, a non-phosphorylatable amino acid. Over-expression of
the StAR wt correlates with the major mitochondrial StAR
content, as observed by immunoblot even in basal cellular
conditions (Figure 3A and B). After hCG-stimulation of cells for
1 h, mitochondrial StAR wt levels increase in the mitochondria,
but not those of the StAR S232A form, indicating that StAR
S232A mutation partially blocks the accessibility of StAR to the
mitochondria (Fig. 3A). The degree of inhibition exerted by the
StAR S232A form correlates with the transfection efficiency rates
(Poderoso et al., 2008) and, as similar results were obtained with
1 h-cAMP stimulation (Figure 3B), this effect might be mediated
by upstream PKA activity. These results suggest that StAR
phosphorylation by ERK is needed for mobilization or retention of
this protein on the OMM. As previously described [28], over-
expression of StAR S232A significantly inhibits P4 production
after hormone stimulation (bottom of each panel).
To confirm that ERK phosphorylation of StAR is effectively the
key event involved in StAR retention at the OMM, we performed
a mitochondrial import and phosphorylation in vitro assay.
Plasmids containing StAR wt and StAR S232A sequences were
subjected to the import assay in the presence of isolated
mitochondria from control cells and recombinant active ERK1.
Then, mitochondrial proteins were subjected to SDS-PAGE,
autoradiography and immunoblot. In Figure 4 we showed that
there is a slight mitochondrial signal of phospho-StAR wt in the
absence the kinase, probably due to some extent of endogenous
mitochondrial ERK. Practically, no signal of phosphorylation of
StAR S232A is observed. The addition of recombinant active
ERK1 provokes a three fold increase in phospho-StAR wt signal
meanwhile StAR S232A signal is not affected. An immunoblot
against pERK is shown to asses the presence of active ERK1 in the
mitochondrial fraction and mitochondrial endogenous ERK, as
mentioned above.
Active ERK1/2 and PKA are Required Along with
Mitochondrial StAR in Order to Attain a Maximal
Steroidogenesis Rate in Mitochondria
Steroidogenesis requires full activity of ERK and PKA localized
at the OMM’s transduceome complex [19,30,31]. Also, mito-
chondrial ERK is transiently activated after hormone stimulation
[28]. Hence, and once we had proven that StAR requires ERK
activity to localize correctly in the mitochondrial context, the
question remained whether both ERK and PKA could contribute
to StAR’s full activity through its retention on the OMM. To
address this issue, we performed a cell-free assay, whose
experimental protocol is indicated in Figure 5A. In Phase I
(Fig. 5B) we observed basal P4 production by mitochondria from
unstimulated cells with a small increase after addition of
recombinant active ERK1 and PKA catalytic subunit (bar a vs.
b), which is probably due to a small amount of mitochondrial
StAR. P4 ratio was higher in mitochondria from 2 h-cAMP-
stimulated cells (bar c vs. a); moreover, steroid synthesis from these
isolated mitochondria was significantly and robustly augmented in
the presence of recombinant active ERK1 and PKA catalytic
subunit (bar d vs. c). These results indicate that, even when StAR
is present after 2 h of cAMP stimulation, ERK and PKA activity
are strongly required to achieve maximal steroid production in this
period of time. In contrast, P4 production was abrogated when
mitochondria were isolated from stimulated cells in the presence of
CCCP (bar e vs. c); since CCCP prevents StAR from reaching the
OMM, neither ERK nor PKA had effects on P4 synthesis (bar f vs.
e). Regarding Phase II (Fig. 5C), when cells were stimulated for 2 h
in the presence of cAMP alone (see bar c), mitochondrial P4
synthesis was maximal in the culture media collected after 3 h (see
bar g), as a consequence of remnant cAMP stimulation in the first
2 h. The addition of ERK and PKA fail to elicit significant
difference in P4, which was probably to the maximal effect
provoked by cAMP in the transduction signal system (bar h vs. g).
We observed that, although CCCP was eliminated for 3 h in
Figure 8. Summary of the proposed mechanisms for the association of StAR to the OMM in MA-10 Leydig cells following hormone
stimulation. After hormone stimulation, mitochondrial fusion induction through Mfn2 up-regulation in mitochondria is needed for increasing StAR
mRNA levels. Also, mitochondrial fusion is required post-transcriptionally for StAR localization at the OMM and subsequent binding to a cholesterol
molecule. Then, cholesterol-bound StAR is available for ERK and PKA mitochondrial phosphorylation, increasing its activity and cholesterol transport.
After the 2 h temporal frame of ERK activity, StAR is dephosphorylated, de-activated and translocated to the mitochondrial matrix where it is
degraded by mitochondrial proteases. Abbreviations: pERK1/2 (phospho-ERK1/2), pStAR: chol (phospho-StAR bound to a cholesterol molecule),
PKA(c) (PKA catalytic subunit), StAR (m) (StAR in the mitochondrial matrix).
doi:10.1371/journal.pone.0100387.g008
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Phase II, mitochondrial P4 synthesis was not reactivated (bar i vs.
g). This result mimics those shown in Figure 1D obtained in whole
cells. However, the incubation of isolated mitochondria (from cells
treated with cAMP and CCCP) with the two constitutively active
kinases yielded a moderate but significant increase in P4
production (bar j vs. i). The strict requirement of active ERK
and PKA was confirmed using specific inhibitors of both
pathways, PD98059 (PD) and H89 respectively. Since these
compounds are not expected to affect constitutively active kinases,
we used them in whole cells. Figure 5D shows that the addition of
H89 or PD98509 to cells incubation media in Phase II (see right
panel) did not elicit any significant change in the low rate of P4
synthesis achieved after CCCP wash-out. The effect of ERK
inhibition is not significant compared to the recovery without
PD98509 since active ERK is not present in mitochondria in this
condition. It might be suggested that PKA activity exhibits a
similar pattern, dependending on the observed effect with H89, or
with the combination of both compounds. Left panel of the Fig. 5D
displays Phase I, as already described in Figure 1.
Mitochondrial Fusion is Associated with the Efficient
Localization of StAR and ERK Activity in Mitochondria
We recently described that Mfn2 is up-regulated by the hCG/
cAMP system in MA-10 Leydig cells and postulated a key role of
mitochondrial fusion in the hormone stimulation of steroidogenesis
[33]. Although StAR is a mitochondrial protein and mitochondrial
fusion is essential for steroid synthesis, data referring to the
involvement of this fusion and the dynamic patterns of StAR are
not available. To determine whether StAR mitochondrial
localization could, at least in part, be mediated by mitochondrial
fusion, we knocked down Mfn2 by the shRNA technique as
described previously [33]. Since we have already validated specific
Mfn2 inhibition in MA-10 cells by means of two different shRNA
constructs [33], we chose one shRNA construct to perform these
experiments. Immunoblot showed that the increase in StAR
mitochondrial signal after hCG and cAMP 1 h-stimulation was
significantly diminished in the presence of Mfn2-shRNA
(Figure 6A) with no effect on StAR basal levels. Interestingly,
Figure 6B shows that mitochondrial ERK activation stimulated by
cAMP and hCG, detected as phosphorylation of the kinase, was
significanlty diminished when Mfn2 levels were knocked down.
Figure 6C shows that Mfn2 was hormonally induced, while the
efficacy of the shRNA treatment in the expression of Mfn2 was
demonstrated by the reduction detected in the mitochondrial
content of this protein. Under these conditions P4 biosynthesis was
also inhibited, as expected (Fig. 6D). These results suggest that
mitochondrial fusion could be involved in: a) StAR protein
mitochondrial localization, b) mRNA StAR abundance which
determines total StAR protein levels or c) a combination of both
effects.
StAR mRNA Levels are Dependent on Mfn2 Presence and
Mitochondrial Fusion
StAR gene expression regulation has been extensively studied in
steroidogenic and even non-steroidogenic tissues [21,22,23,47,48].
However, little is known about post-transcriptional regulation of
StAR synthesis. Previous reports indicate that stabilization of
StAR mRNA is one mechanism involved in the regulation of
StAR mRNA total levels [41,49,50]. Moreover, previous reports
show that Mfn2 protein levels regulate the mRNA abundance of
different proteins [51,52]. In order to further explore the potential
role of mitochondrial fusion in total cellular levels of StAR mRNA,
we examined its content under hormone stimulation in Mfn2
knocked down cells. We observed that the abrogation of Mfn2
levels significantly inhibited StAR mRNA abundance after 1 h of
cAMP stimulation (Figure 7). This work shows, for the first time,
that mitochondrial fusion is involved, at least in part, in
modulation of StAR mRNA levels in the cell.
Discussion
In this study we have demonstrated that steroidogenesis in MA-
10 Leydig cells depends on the hormonally-stimulated mitochon-
drial fusion that regulates StAR mRNA and protein abundance
and therefore its translocation to the mitochondria. We have
shown for the first time that mitochondrial ERK1/2 activation is
an essential step in localization, activity and/or retention of StAR
on the OMM.
We determined that StAR protein is effectively translocated to
the matrix after the DYm is restored, as determined by the
detection of the 30 kDa processed StAR. Even though we
observed a significant amount of mitochondrial StAR levels after
a 2 and 3 h wash-out of CCCP, P4 production in Phase II was not
reactivated in any recovery time evaluated. (Fig. 1).
P4 synthesis rate was not reactivated even when mitochondrial
function was normalized and StAR localized at the matrix; then, it
appears that StAR presence in the mitochondrial matrix per se is
not sufficient to recover steroidogenesis. It is conceivable that other
mitochondrial factors, which are unable to reach the mitochondria
when CCCP is added to the culture media, are involved in StAR
activation in Phase I. Mitochondrial ERK can be suggested as a
good candidate to cooperate with StAR in Phase I to achieve
maximal P4 production, since its activation/deactivation cycle
correlates with the time-course of Phase I/II respectively. This
notion is reinforced by the fact that mitochondrial ERK activation
is impared in the presence of CCCP; nevertheless, pERK levels
are not restored after CCCP wash-out in Phase II.
Since CCCP affected StAR mRNA total levels (Fig. S1) and
over-expressed exogenous StAR mitochondrial presence is blocked
by CCCP, results from Figures 1 and 2 together suggest that
inhibition of DYm affects StAR mitochondrial localization at both
transcriptional and post-transcriptional level; for example, reten-
tion at the OMM.
We showed that over-expression of StAR S232A significantly
abolishes the presence of mitochondrial StAR after hCG or cAMP
stimulation. ERK phosphorylation affects post-transcriptionally
mitochondrial StAR levels,. since expression of transfected StAR is
independent of endogenous regulation. In MA-10 cells, a
mitochondrial module includes MEK (Mitogen-activated protein
kinase kinase), ERK and cholesterol with a direct physical
association between StAR and ERK [28]. Their interaction favors
StAR phosphorylation by ERK and hence could promote
phospho-StAR retention in the mitochondria, particularly on the
OMM where ERK resides [30]. It is the OMM localization of
StAR, and not its cleavage from the 37 kDa to the 30 kDa form,
that determines its activity [12]. Then, the longest StAR retention
time at the OMM might render the maximal StAR activity in
cholesterol transport, in agreement with previous data [14]. ERK
is transiently activated after hormone stimulation in MA-10 cells
and is dephosphorylated as a normal regulation pathway, mainly
by the Mitogen-activated protein kinase phosphatases (MKPs)
[28,53,54]. Interaction between phospho-StAR and ERK in
mitochondria could protect ERK from dephosphorylation and
inactivation. The temporal frame of ERK activity (1–2 h) in
mitochondria correlates with the period of StAR major activity
and cholesterol transport after hormone stimulation. These results
are entirely in line with the MKP-1 down-regulation and the
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concomitant P4 increase after 2 h of stimulation, probably due to
a long-lasting effect of active ERK in mitochondria [42]. If CCCP
is present in 15 min-ACTH stimulation in Y1 adrenal cells, most
of the steroid production is recovered after 15 min wash-out [9],
which is consistent with full mitochondrial ERK activity.
Results depicted in Figures 4 and 5 clearly support the
conclusions above. The low P4 values obtained in isolated
mitochondria when StAR is present after CCCP wash-out mimic
results observed in whole MA-10 cells. The presence of both active
kinases promotes a significant increase in P4 production, thereby
validating the obligatory role of ERK and PKA as required
mediators in mitochondria to elicit the maximal steroidogenesis
rate. These conclusions are supported by the lack of effect of ERK
and PKA inhibitors on cellular P4 production in Phase II. If the
accesibility of PKA and ERK to the mitochondria is allowed when
mitochondrial StAR is present, then P4 production is maximal.
In this work we have clearly shown that mitochondrial fusion
through the increase of Mfn2 levels in mitochondria is strictly
required for StAR protein synthesis and mitochondrial localization
after hormone stimulation by hCG and cAMP. Mitochondrial
fusion reduction correlates with a decrease in StAR protein in
mitochondria and mRNA levels. The results obtained with Mfn2
knockdown are entirely consistent with those observed with CCCP
treatments, suggesting that the effect of CCCP might be partially
due to mitochondrial fusion inhibition. In this regard, we have
demonstrated here that ERK mitochondrial activity depends on
Mfn2 presence in mitochondria, in agreement with the lack of
steroidogenic capacity of cells in the presence of CCCP and with
previous published work [33].
A direct role of Mfn2 on StAR gene expression is unknown to
date. In this regard, a previous report shows that over-expression
or knockout of Mfn2 modulates and affects mRNA levels of several
mitochondrial proteins [51,52]. We have described an arachidonic
acid [55] generation/exportation system that includes an Acyl-
CoA synthetase 4 (Acsl4) [38,40,56]. Acsl4 is anchored at the
MAM (mitochondrial associated-membrane) structures [57] and
its activity determines the production rate of AA which is
necessary for StAR gene expression [22]. Our previous work
demonstrated that mitochondrial fusion to the ER (MAM) is
required for the correct localization of Acsl4, after hormone
stimulation [33]. Therefore, mitochondrial fusion can be suggested
to participate in StAR synthesis regulation through Acsl4
regulation and MAMs localization; thereby increasing the
intramitochondrial AA and leukotrienes production. It is worth
mentioning that a stabilizing effect of mitochondrial fusion on
StAR mRNA cannot be excluded. Interestingly, a report has
proposed that the different variants of StAR mRNA levels are
regulated by stabilization mediated by cAMP in MA-10 cells
[41,49]. Recently, StAR mRNA was shown to bind a mitochon-
drial AKAP1 stabilizing the translational complex at this organelle
[50]. Therefore, mitochondrial fusion could mediate the approach
between StAR mRNA and the AKAP1 in mitochondria, thus
stabilizing and increasing StAR mRNA levels, as shown in this
work.
Figure 8 depicts mechanisms involved in StAR activity
associated with the transduceome localized on the OMM,
including the relevance of mitochondrial fusion and ERK activity
on StAR as fundamental steps. This representation is fully
consistent with the mechanism proposed by Miller and co-workers
[12,14].
Conclusions
Briefly, we may conclude that mitochondrial fusion stimulated
by steroidogenic hormones, through the cAMP pathway, defines
not only StAR mRNA levels in the cell but also the localization of
active StAR protein in the mitochondria. Indeed, the StAR
phospho/dephosphorylation cycle could be mediated by ERK
activity and mitochondrial phosphatases in the context of the
OMM, enabling a very small amount of mitochondrial StAR to be
responsible for the very large number of steroid molecules
produced in a short period of time.
Supporting Information
Figure S1 Effect of CCCP on StAR mRNA levels. Cells
were subjected to the two-phase experiment. Total RNA was
isolated, reverse transcribed and subjected to semi-quantitative
PCR using specific primers for StAR and L19 cDNA, as loading
control. PCR products were resolved in ethidium bromide-stained
agarose gels. Treatments and corresponding phases are indicated
in the figure. A representative gel is shown. For each band, the
OD of the expression levels of StAR were quantified (arbitrary
units) and normalized to the corresponding L19 abundance. The
relative levels of StAR are shown: **p,0.001 vs. Phase I; ¥¥¥ p,
0.001 vs. control; ns p.0.05 vs. control CCCP. All the results are
expressed as means 6 SEM of three independent experiments.
(TIF)
Table S1 Effect of CCCP on P4 production sustained by
22(R)-OH-cholesterol. P4 production was measured by RIA in
the culture media in the presence or absence of 22(R)-OH-
cholesterol and CCCP, at the indicated times. Data are shown as
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